Benjamin L. Palleiko

Chief Executive Officer at KalVista Pharmaceuticals · 28 reported transactions in 1 company · latest trade May 22, 2026

Their trades


KalVista PharmaceuticalsKALV	Sold $292.6K · 10,926 shares	May 22, 2026
KalVista PharmaceuticalsKALV	Sold $30.2K · 1,129 shares	May 18, 2026
KalVista PharmaceuticalsKALV	Sold $156.2K · 10,034 shares	Feb 23, 2026
KalVista PharmaceuticalsKALV	Sold $15.6K · 1,038 shares	Feb 18, 2026
KalVista PharmaceuticalsKALV	Sold $52.7K · 3,354 shares	Feb 12, 2026

May 22, 2026 · KALV

$292.6K

May 18, 2026 · KALV

$30.2K

Feb 23, 2026 · KALV

$156.2K

Feb 18, 2026 · KALV

$15.6K

Feb 12, 2026 · KALV

$52.7K

Newest 10 of 28 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Chief Executive Officer at KalVista Pharmaceuticals · 28 reported transactions in 1 company · latest trade May 22, 2026


KalVista PharmaceuticalsKALV	Sold $292.6K · 10,926 shares	May 22, 2026
KalVista PharmaceuticalsKALV	Sold $30.2K · 1,129 shares	May 18, 2026
KalVista PharmaceuticalsKALV	Sold $156.2K · 10,034 shares	Feb 23, 2026
KalVista PharmaceuticalsKALV	Sold $15.6K · 1,038 shares	Feb 18, 2026
KalVista PharmaceuticalsKALV	Sold $52.7K · 3,354 shares	Feb 12, 2026